Exosomes are rapidly emerging as a transformative frontier in regenerative science and advanced skincare. From research labs to commercial applications, industry interest is accelerating globally. However, as innovation scales, so does the need for credible, compliant, and scalable partners.
The global exosome-based skincare market is estimated to grow at a CAGR of 10.5% between 2024-2033. (https://www.giiresearch.com/report/sky1838213-exosomes-skincare-market-size-share-growth.html)
As the industry evolves, the focus is shifting from what exosomes are to how they can be developed, validated, and scaled responsibly.
We operate with our sister concern, as an integrated CMO, CDMO, and CRO, supporting partners across the lifecycle.
- Development & manufacturing of customized formulations
- Testing & characterization to ensure consistency and compliance
- Global market readiness across regulatory environments
With globally recognized accreditations and a multidisciplinary scientific team, we focus on delivering solutions that balance innovation with compliance and scalability.
Building on the momentum of the past year, we welcome discussions with partners looking to advance scalable, science-backed exosome solutions in 2026 and beyond.
